Study guide
2.3 Source Documentation, ALCOAC Principles & Medical Record Standards
ACRP Certified Professional ACRP-CP
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: GCP Principles, Roles & Delegation
1.1 The Eleven ICH E6(R3) Principles of GCP & Guideline Structure 1.2 Sponsor & Investigator Responsibilities and Delegation of Authority 1.3 Staff Training, Qualifications & Delegation of Authority Log (DOAL) 1.4 CRO Oversight, Vendor Management & Transfer of Regulatory Obligations (TORO)
2 Chapter 2: Essential Records, Source Documentation & Data Confidentiality
2.1 Essential Records Before, During and After the Trial (ICH E6(R3) Appendix C) 2.2 Trial Master File (TMF) and Investigator Site File (ISF) Structure & Inspection Readiness 2.3 Source Documentation, ALCOAC Principles & Medical Record Standards 2.4 Confidentiality, Privacy & Protection of Participant Personal Information
3 Chapter 3: Monitoring, Quality Management & Audits
3.1 Risk-Based Quality Management (RBQM) & Quality Management Systems (QMS) 3.2 Monitoring Visit Types: Site Selection, SIV, IMV, and Close-Out 3.3 Risk-Based Monitoring (RBM), Centralized Monitoring & Source Data Verification (SDV vs SDR) 3.4 Quality Audits, Regulatory Inspections, Non-Compliance & Root Cause Analysis / CAPA
4 Chapter 4: Site Feasibility, Start-Up, Facilities & Laboratory Operations
4.1 Site Feasibility Assessment, Capability Analysis & Investigator Selection 4.2 Contractual Agreements: Clinical Trial Agreements, Budgets, Indemnification & Financial Arrangements 4.3 Site Initiation Preparation, System Access & Regulatory Greenlight 4.4 Protocol Review, Operational Feasibility & Institutional Approvals 4.5 Site Facilities, Equipment Maintenance, Calibration & Trial Supplies 4.6 Biological Samples & Hazardous Goods: Collection, Storage, Disposal & Shipment
5 Chapter 5: Subject Recruitment, Retention & Study Visits
5.1 Subject Recruitment Strategies, Advertising Guidelines & Ethical Constraints 5.2 Screening, Eligibility Verification & Inclusion/Exclusion Adherence 5.3 Subject Retention, Compliance, Visit Scheduling & Protocol Window Management 5.4 Managing Lost to Follow-Up, Subject Withdrawal & Early Termination Procedures
6 Chapter 6: Protocol Compliance, Deviations & Site Close-Out
6.1 Protocol Compliance, Waivers vs. Violations & Deviation Management 6.2 Investigational Site Close-Out Activities & Final Reconciliations 6.3 Record Retention, Archiving Requirements & Post-Trial Responsibilities
7 Chapter 7: Research Ethics, Vulnerable Populations & Research Integrity
7.1 Historical Milestones: Nuremberg Code, Belmont Report & Declaration of Helsinki 7.2 Ethical Principles: Beneficence, Non-Maleficence, Autonomy, Justice & Equipoise 7.3 Vulnerable Populations (Pediatrics, Pregnant Women, Prisoners, Cognitively Impaired, Economically Disadvantaged) 7.4 Conflict of Interest, Research Misconduct & Fraud in Clinical Research
8 Chapter 8: Informed Consent & Institutional Review Boards (IRB/IEC)
8.1 Informed Consent Elements, Process & Ongoing Consent / Re-Consent Requirements 8.2 Assent in Minors & Legally Acceptable Representative (LAR) Requirements 8.3 IRB/IEC Composition, Functions, Review Types (Full, Expedited, Exempt) & Continuing Review
9 Chapter 9: Safety Reporting & Adverse Event Management (ICH E2A)
9.1 Adverse Events (AE) vs. Adverse Drug Reactions (ADR) & Serious Adverse Events (SAE) Definitions 9.2 Causality Assessment, Expectedness, Reference Safety Information (RSI) & SUSARs 9.3 Expedited Reporting Timelines (7-day fatal/life-threatening, 15-day other serious) & Periodic Safety Updates (DSUR)
10 Chapter 10: Investigational Product (IP) Management & Accountability
10.1 Investigational Product Lifecycle, Labeling, Packaging & Blinding Procedures 10.2 IP Shipping, Receipt, Temperature Monitoring, Excursion Handling & Chain of Custody 10.3 IP Storage, Dispensing, Accountability Logs & Destruction/Return Procedures 10.4 Emergency Unblinding (Code Breaking) Protocols & Subject Safety Procedures
11 Chapter 11: Regulatory Frameworks, Submissions & Product Reference Information
11.1 Stakeholders, Regulatory Institutions & Global Frameworks in Clinical Research 11.2 Protocol Submission, Approval & Amendment Processes 11.3 Investigator's Brochure, Instructions for Use & Reference Product Information 11.4 Regulatory Reporting Requirements Before and After Marketing Authorisation
12 Chapter 12: Clinical Data Management, EDC & Electronic Records
12.1 Electronic Data Capture (EDC), eCRF Design & Clinical Data Management Systems (CDMS) 12.2 Computerised Systems, Data Governance & Audit Trails (ICH E6(R3) Annex 1 §4) 12.3 Data Validation, Edit Checks, Discrepancy / Query Management & Resolution 12.4 Medical Coding (MedDRA, WHO Drug), SAE Reconciliation, Data Transfer & Database Lock
13 Chapter 13: Trial Design, Biostatistics, Data Monitoring & Transparency
13.1 Phases of Clinical Research (Phase 0, I, II, III, IV) & Translational Medicine 13.2 Study Designs: Parallel, Crossover, Factorial, Adaptive & Non-Inferiority / Equivalence 13.3 Randomization Schemes, Stratification, Blinding Methods & Minimizing Bias 13.4 Endpoints (Primary, Secondary, Surrogate, Composite), Sample Size & Biostatistical Concepts (p-values, CI, ITT vs PP) 13.5 Interim Analyses, DSMB/IDMC Oversight & Efficacy and Safety Evaluation Milestones 13.6 Trial Registration, Results Transparency & Communicating Results to Participants
2.3 Source Documentation, ALCOAC Principles & Medical Record Standards
Key Takeaways Explain This Topic AI
Source data comprises all information in original records and certified copies of original clinical findings, observations, or trial activities necessary for reconstruction and evaluation.
The ALCOAC / ALCOA+ framework defines the non-negotiable quality criteria for all clinical data: Attributable, Legible, Contemporaneous, Original, Accurate, and Complete (plus Consistent, Enduring, and Available).
A Certified Copy must be verified via a dated signature or validated process to have the exact same information, content, context, and structure as the original record (the ICH E6(R3) Glossary).
Corrections to paper records must follow the single-line strike-through method with date, initials, and explanation without obscuring original entries; electronic systems enforce this via automated audit trails.
Backdating records or fabricating entries represents severe scientific misconduct and criminal fraud; late entries must always be documented with the current date, time, and explicit late-entry notation.
Last updated: August 2026
2.3 Source Documentation, ALCOAC Principles & Medical Record Standards
ACRP-CP Exam Focus: "If it wasn't documented, it didn't happen!" Source documentation represents the bedrock of clinical research. Candidates must master the regulatory definitions of source data and source documents (the ICH E6(R3) Glossary / 1.52), the 9 dimensions of ALCOAC / ALCOA+, certified copy requirements, Electronic Health Record (EHR/EMR) integration standards, and the strict rules governing error corrections on both paper and electronic platforms.
1. Regulatory Definitions: Source Data vs. Source Documents vs. CRFs
Understanding the precise legal distinction between source data, source documents, and Case Report Forms (CRFs) is critical for clinical research professionals. +---------------------------------------------------------------------------------------------+
- | ICH E6(R3) GLOSSARY DEFINITIONS |
- +-----------------------+---------------------------------------------------------------------+
- | Term | Official Definition & Scope |
- +-----------------------+---------------------------------------------------------------------+
- | **Source Data** | All information in original records and certified copies of |
- | (the ICH E6(R3) Glossary) | original records of clinical findings, observations, or other |
- | | activities in a clinical trial necessary for the reconstruction and |
- | | evaluation of the trial. |
- +-----------------------+---------------------------------------------------------------------+
- | **Source Documents** | Original documents, data, and records (e.g., hospital records, |
- | (the ICH E6(R3) Glossary) | clinical/office charts, laboratory notes, memoranda, subjects' |
- | | diaries, pharmacy dispensing records, recorded data from automated |
- | | instruments, certified copies, microfiches, x-rays, etc.). |
- +-----------------------+---------------------------------------------------------------------+
- | **Case Report Form** | A printed, optical, or electronic document designed to record all |
- | (CRF / eCRF) | of the protocol-required information to be reported to the sponsor |
- | (the ICH E6(R3) Glossary) | on each trial subject. |
- +-----------------------+---------------------------------------------------------------------+
- The Fundamental Principle of Source Verification
The Case Report Form (CRF) is a data reporting tool, not the source document, unless the protocol or formal Data Management Plan explicitly pre-specifies direct data entry (e.g., electronic patient-reported outcomes / ePRO questionnaires where data originates directly in the tablet). In all other cases, data entered into the eCRF must be verifiable against original source records located at the investigational site.
2. The ALCOAC / ALCOA+ Quality Framework
The ALCOA framework, originally formulated by the FDA and expanded internationally into ALCOAC (and ALCOA+ ), outlines the mandatory standards that every piece of clinical data must fulfill to ensure regulatory acceptability.
- Deep-Dive Analysis of ALCOAC / ALCOA+ Principles THE ALCOAC QUALITY MATRIX
- +--------------------------------------------------------------------------+
- | A - ATTRIBUTABLE : Who observed and recorded the data, and when? |
- | L - LEGIBLE : Can the data be clearly read and interpreted? |
- | C - CONTEMPORANEOUS: Was the entry recorded at the time of event? |
- | O - ORIGINAL : Is it the primary first recording or certified copy?|
- | A - ACCURATE : Is the entry truthful, precise, and error-free? |
- | C - COMPLETE : Are all required elements and context present? |
- +--------------------------------------------------------------------------+
- | + CONSISTENT : Do records align across all systems without conflict?|
- | + ENDURING : Will the media survive decades of archival storage? |
- | + AVAILABLE : Can records be retrieved promptly for inspection? |
- +--------------------------------------------------------------------------+
Detailed Breakdown of Each Dimension:
Attributable (A):
Every piece of data, observation, signature, or correction must clearly identify the individual who performed the assessment and recorded the entry.
In paper records: handwritten signature or initials accompanied by the date.
In electronic systems: unique user credentials linked to Part 11 compliant electronic signatures with automated timestamps.
Prohibited: Sharing system passwords, signing for colleagues, or pre-signing blank forms.
Legible (L):
Data must be easily readable across its entire lifecycle. In paper records, dark, permanent ink must be used.
In electronic records, font clarity, formatting, and high-resolution scanning must prevent loss of legibility over time.
Prohibited: Use of pencil, erasable pens, or obscuring corrections with white-out.
Contemporaneous (C):
Documentation must be executed in real time—at the exact time the examination, procedure, or drug dispensing occurs.
When immediate recording is clinically impossible, any subsequent documentation must be recorded as a "Late Entry" noting both the actual date/time of recording and the historical date/time the event occurred.
Prohibited: Backdating entries or reconstructing clinic visits weeks later from memory.
Original (O):
The primary, first recording of the data. If a clinician writes vitals on a paper towel or scrap sheet, that scrap legally becomes the original source document!
To avoid unstructured paper scraps, sites must implement formal, version-controlled Source Document Templates / Worksheets .
If originals cannot be retained, a formally Certified Copy must be created.
Accurate (A):
Data must be truthful, mathematically correct, and consistent with the clinical reality.
Source documents must capture raw data without rounding errors, unverified assumptions, or contradictory statements.
Complete (C):
Records must provide the full clinical context, including negative findings, omitted doses, missed assessments, and clinical rationale for deviations.
All fields on source worksheets must be completed; if a test was not done, record "Not Done (ND)" or "Not Applicable (NA)" with an explanation.
Consistent (+):
Data across disparate systems (e.g., nursing notes, physician progress notes, lab requisitions, ECG printouts) must demonstrate chronological and factual agreement.
Enduring (+):
Data must remain intact on durable media for the full statutory retention period (often 15–25+ years).
Critical Compliance Rule: Thermal paper printouts (such as ECG rhythm strips or autoclave logs) fade within months; they must be photocopied and certified immediately.
Available (+):
Records must be readily accessible for review by monitors, auditors, and regulatory inspectors during on-site and remote audits.
3. Certified Copies in Clinical Research
Under ICH GCP E6(R3) Glossary , a Certified Copy is formally defined as: Certified Copy = A copy of original information that has been verified (via dated signature or validated process) to have the same information, context, content, and structure. \text{Certified Copy} = \begin{array}{l} \text{A copy of original information that has been verified (via dated signature} \\ \text{or validated process) to have the same information, context, content, and structure.} \end{array} Certified Copy = A copy of original information that has been verified (via dated signature or validated process) to have the same information, context, content, and structure.
The Certified Copy Protocol:
Visual & Structural Verification: The certifier must verify that all pages, front-and-back text, marginal notes, stamps, and attachments are fully legible and present.
Certification Statement: A formal stamp or written statement must be applied:
"I hereby certify that this document is a true, accurate, and complete copy of the original record."
Signature and Date: The individual verifying the copy must physically sign (or apply a validated electronic signature) and date the certification on the date the verification takes place. +---------------------------------------------------------------------------------------------+
- | THE THERMAL PAPER ECG CERTIFICATION RULE |
- | |
- | Scenario: A 12-lead ECG is printed on thermal paper during a screening visit. |
- | Risk: Thermal paper reacts to light, heat, and time, completely fading within 6–12 months. |
- | Correct Action: |
- | 1. CRC makes a clean, high-resolution photocopy of the thermal printout on standard paper. |
- | 2. CRC compares photocopy to original thermal strip to confirm identical waveform data. |
- | 3. CRC stamps "Certified True Copy," signs, and dates the photocopy on that day. |
- | 4. The certified photocopy is filed in the subject's permanent research chart. |
- +---------------------------------------------------------------------------------------------+
4. Electronic Health Records (EHR / EMR) as Clinical Source Data
Most investigational sites utilize institutional Electronic Health Records (EHR / EMR) (such as Epic, Cerner, or Allscripts) as primary source systems. The FDA Guidance on Use of Electronic Health Record Data in Clinical Investigations establishes key principles:
Key Regulatory Requirements for EHR Source Data:
System Security & Part 11 Alignment: EMR systems must incorporate access controls, user authentication, and tamper-evident audit trails that log every viewing, entry, modification, and deletion.
Monitor & Auditor Access: Sponsors and CRAs must be granted direct, read-only access to relevant subject medical records to conduct Source Data Verification (SDV) and Source Data Review (SDR) without exposing non-trial patient data.
Audit Trail Inspection: Regulatory inspectors have the right to request and inspect EHR audit trails to verify that entries were recorded contemporaneously and identify any unauthorized retrospective edits.
5. Strict Standards for Correcting Errors in Clinical Records
Errors inevitably occur in clinical practice. What distinguishes compliant clinical research from regulatory non-compliance is how corrections are documented.
Paper-Based Error Correction: The Single-Line Rule +---------------------------------------------------------------------------------------------+
- | HOW TO CORRECT A PAPER SOURCE RECORD |
- | |
- | WRONG WAY: Use white-out, blackout markers, scribble over errors, or backdate entries. |
- | [WHITE-OUT] ===> ILLEGAL / REGULATORY CITATION |
- | |
- | RIGHT WAY: 1. Draw a SINGLE horizontal line through incorrect entry (must remain legible)|
- | 2. Write correct value adjacent to original entry. |
- | 3. Initial and Date on the CURRENT calendar date. |
- | 4. Document brief explanation if reason for change is not self-evident. |
- | |
- | Example: 140/90 120/80 JD 15-AUG-2026 (Transposition error) |
- | ------ |
- +---------------------------------------------------------------------------------------------+
Electronic Systems (eCRF / EDC) Error Correction:
In EDC platforms, modifying a saved field automatically opens a mandatory "Reason for Change" dialogue box.
The user must select or type an accurate explanation (e.g., Transcription error, Data clarification request, Updated lab report ).
The electronic system maintains the previous value, new value, user identity, and timestamp permanently in the audit trail.
Document Falsification vs. Late Entries
Backdating: Writing a past date next to a signature made today is fraudulent backdating and constitutes severe regulatory non-compliance.
Late Entry: Legitimate and compliant when documented transparently:
*"Late Entry for Visit 2 (conducted on 10-AUG-2026): Subject reported mild headache resolving without medication. Documented on 15-AUG-2026 by Jane Doe, RN, CRC."